Chemical Structure (Trudhesa 01)
Trudhesa Spray, Metered
Product Images NDC 77530-725
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 24 technical images submitted to the FDA as part of the official labeling for Trudhesa (NDC 77530-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Impel Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Trudhesa 02)
Figure 2 (Trudhesa 03)
This is a table showing the estimated probability of response to study medication in percentage for studies 3 and 4 with 97 participants receiving Dihydroergotamine Mesylate and 100 receiving Placebo. The time from the first dose is not available.*
Figure 3 (Trudhesa 04)
Image (Trudhesa 05)
Figure (Trudhesa 06)
Figure (Trudhesa 07)
The text appears to be a jumbled combination of letters, symbols, and numbers, making it not available.*
Figure (Trudhesa 08)
Figure A (Trudhesa 09)
Figure B (Trudhesa 10)
Figure C (Trudhesa 11)
Figure D (Trudhesa 12)
Figure E (Trudhesa 13)
Figure F (Trudhesa 14)
Figure G (Trudhesa 15)
Figure H (Trudhesa 16)
Figure I (Trudhesa 17)
Figure J (Trudhesa 18)
Figure K (Trudhesa 19)
This text provides instructions on how to properly prime a nasal spray device by pumping it exactly four times. It also instructs the user to press and then release the device.*
Figure L (Trudhesa 20)
Figure M (Trudhesa 21)
Figure N (Trudhesa 22)
Figure O (Trudhesa 23)
Principal Display Panel (0.725 mg Vial Carton)
Trudhesa is a medication used for treating migraines without aura. It contains dihydroergotamine mesylate which helps in treating headaches. The medication is available in the form of nasal spray devices and Trudhesa vials that come with instructions for use and prescribing information. The recommended dosage should be followed as per the instructions mentioned in the prescribing information. The medication should be kept at room temperature and should not be refrigerated or frozen. The contents of the nasal spray devices are disposable and should be discarded after use.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
